Chembio Diagnostics, Inc. Recorded Big Gain

Wed, Jul 21, 2021 at 05:30 PM
Chembio Diagnostics, Inc. Recorded Big Gain

Chembio Diagnostics, Inc. (CEMI:NASDAQ) rocketted at $5.34, representing a gain of 159.2%. On Tue, Jul 20, 2021, CEMI:NASDAQ touched a New 2-Week Low of $2.06. The stock got featured on our News Catalysts scanner on Wed, Jul 21, 2021 at 10:53 AM in the 'MISCELLANEOUS' category. From Tue, Jul 06, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Tue, Jan 26, 2021 at $8.75 with a volume of 2M+.

About Chembio Diagnostics, Inc. (CEMI:NASDAQ)

Chembio Diagnostics Inc develops, manufacture markets & licenses rapid point of care diagnostic tests that detect infectious diseases. Its products are rapid tests for the detection of HIV 1/2 antibodies, & for the detection of HIV & Syphilis antibodies.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.